EXPERIMENTAL EVALUATION OF POTENTIAL ANTICANCER AGENTS. XIII. ON THE CRITERIA AND KINETICS ASSOCIATED WITH "CURABILITY" OF EXPERIMENTAL LEUKEMIA.

No abstract is available for this paper.

• Publication year

  1964

• Venue

  Cancer chemotherapy reports

• Publication date

  1964-02-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 14117037
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Mathematical analysis of metronomic chemotherapy response in metastatic gastrointestinal cancer: identifying critical parameters from clinical data

  2026cites this paper
• Can evolutionary therapy be applied in non-small cell lung cancer?

  2026cites this paper
• Modeling MRD Changes in Myeloma to Understand Treatment Effects, Predict Outcomes, and Investigate Curative Potential

  2025cites this paper
• A model of intra-tumor and inter-patient heterogeneity explains clinical trials of curative combination therapy for lymphoma.

  2025cites this paper
• Anti-cancer drug administration in cancer treatment under stochastic disturbances: modeling and numerical optimization algorithms

  2025cites this paper
• Meshfree analysis of brain tumor growth under various treatment plans considering the mechanical stress effect

  2025cites this paper
• Autophagy in doxorubicin resistance: basic concepts, therapeutic perspectives and clinical translation

  2025cites this paper
• Evolutionary antifragile therapy

  2025cites this paper
• Mathematical Oncology: How Modeling Is Transforming Clinical Decision Making.

  2025cites this paper
• Computational modelling of CAR T-cell therapy: from cellular kinetics to patient-level predictions

  2025cites this paper
• Optimum design of type-2 fuzzy controller using chaos game optimization algorithms, marine predators and slime mold for chemotherapy drug injection rate in cancer treatment

  2024cites this paper
• Conventional chemotherapy: millions of cures, unresolved therapeutic index

  2024cites this paper
• Molecular panorama of therapy resistance in prostate cancer: a pre-clinical and bioinformatics analysis for clinical translation

  2024cites this paper
• Dynamic Modelling and Robust Control of Cancer Mutation Employing Sliding Mode Based Chemotherapy

  2024cites this paper
• Robust Control for Cancer Chemotherapy Through Time Delayed Estimation Philosophy

  2024cites this paper
• A mechanistic model of curative combination therapy explains lymphoma clinical trial results

  2024cites this paper
• 6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7)

  2024cites this paper
• A Bayesian Dynamic Model‐Based Adaptive Design for Oncology Dose Optimization in Phase I/II Clinical Trials

  2024cites this paper
• Metronomic chemotherapy in cancer treatment: new wine in an old bottle

  2024cites this paper
• Deep reinforcement learning control of combined chemotherapy and anti-angiogenic drug delivery for cancerous tumor treatment

  2024cites this paper
• Real-Time Image Analysis Software Suitable for Resource-Constrained Computing

  2024cites this paper
• Inheritable cell-states shape drug-persister correlations and population dynamics in cancer cells

  2024cites this paper
• Early life cancer and chemotherapy lead to cognitive deficits related to alterations in microglial-associated gene expression in prefrontal cortex.

  2023cites this paper
• Anisotropic, Hydrogel Microparticles as pH-Responsive Drug Carriers for Oral Administration of 5-FU

  2023cites this paper
• Mathematical Modeling Support for Lung Cancer Therapy—A Short Review

  2023cites this paper
• Treatment of evolving cancers will require dynamic decision support

  2023cites this paper
• Drug independence and the curability of cancer by combination chemotherapy.

  2022influential citation
• Working with Convex Responses: Antifragility from Finance to Oncology

  2022cites this paper
• Myriad: a real-world testbed to bridge trajectory optimization and deep learning

  2022cites this paper
• Clinical and Biological Aspects of Disseminated Tumor Cells and Dormancy in Breast Cancer

  2022cites this paper
• Root Bark Extract of Oroxylum indicum Vent. Inhibits Solid and Ascites Tumors and Prevents the Development of DMBA-Induced Skin Papilloma Formation

  2022cites this paper
• Design and implementation of an adaptive fuzzy sliding mode controller for drug delivery in treatment of vascular cancer tumours and its optimisation using genetic algorithm tool

  2022cites this paper
• Additivity predicts the efficacy of most approved combination therapies for advanced cancer

  2022influential citation
• Optimal control methods for drug delivery in cancerous tumour by anti‐angiogenic therapy and chemotherapy

  2021cites this paper
• Experimental Validation of a Mathematical Model to Describe the Drug Cytotoxicity of Leukemic Cells

  2021cites this paper
• Optimization assisted Kalman filter for cancer chemotherapy dosage estimation

  2021cites this paper
• Finite-Time Fuzzy Control Design for Drug Dosage Delivery in Cancer Treatment

  2021cites this paper
• Dosage strategies for delaying resistance emergence in heterogeneous tumors

  2021cites this paper
• Translationally relevant mouse model of early life cancer and chemotherapy exposure results in brain and small intestine cytokine responses: a potential link to cognitive deficits.

  2021cites this paper
• A Framework for Modeling and Efficacy Evaluation of Treatment of Cancer with Metastasis

  2021cites this paper
• Adaptive fuzzy controller design of drug dosage using optimal trajectories in a chemoimmunotherapy cancer treatment model

  2021cites this paper
• Combination Chemotherapy Optimization with Discrete Dosing

  2021cites this paper
• How translational modeling in oncology needs to get the mechanism just right

  2021cites this paper
• Battling Chemoresistance in Cancer: Root Causes and Strategies to Uproot Them

  2021cites this paper
• Artificial intelligence and mechanistic modeling for clinical decision making in oncology.

  2020cites this paper
• Mathematics + Cancer: An Undergraduate "Bridge" Course in Applied Mathematics

  2020cites this paper
• Tumor Growth Dynamic Modeling in Oncology Drug Development and Regulatory Approval: Past, Present, and Future Opportunities

  2020cites this paper
• Machine Learning Method Used to find Discrete and Predictive Treatment of Cancer

  2020cites this paper
• Drug-Resistant Cancer Treatment Strategies Based on the Dynamics of Clonal Evolution and PKPD Modeling of Drug Combinations

  2020cites this paper
• Descriptive and prognostic value of a computational model of metastasis in high-risk neuroblastoma

  2020cites this paper
• How mathematical modeling could contribute to the quantification of metastatic tumor burden under therapy: insights in immunotherapeutic treatment of non-small cell lung cancer

  2020cites this paper
• Cell and extracellular matrix growth theory and its implications for tumorigenesis.

  2020cites this paper
• Impact of Cisplatin Dosing Regimens on Mammary Tumor Growth in an Animal Model

  2020cites this paper
• Knowledge, Attitude and Awareness about Anticancer Antibiotics among Dental Students

  2020cites this paper
• Clone Wars: Quantitatively Understanding Cancer Drug Resistance.

  2020cites this paper
• Evaluation of the contribution of randomised cancer clinical trials evaluating agents without documented single-agent activity

  2020cites this paper
• Towards Personalized Radio-Chemotherapy - Learning from Clinical Data vs. Model Optimization

  2020cites this paper
• Generalized Additive Mixed Modeling of Longitudinal Tumor Growth Reduces Bias and Improves Decision Making in Translational Oncology

  2020cites this paper
• Principles of Chemotherapy in Hodgkin Lymphoma

  2020cites this paper
• Developments over the last 60 years in diffuse large B‐cell lymphomas

  2020cites this paper
• Amsacrine

  2020cites this paper
• Antifragile therapy

  2020cites this paper
• Delivering HDAC over 3 or 5 days as consolidation in AML impacts health care resource consumption but not outcome.

  2020cites this paper
• Doxorubicin uptake in ascitic lymphoma model: resistance or curability is governed by tumor cell density and prolonged drug retention

  2020cites this paper
• Combination Chemotherapy Optimization

  2020cites this paper
• Time Series Data to Mathematical Model

  2020cites this paper
• PhD Dissertation Summary: In search of concise mathematical description of drug-resistant tumour growth

  2020cites this paper
• Derivation of an optimal trajectory and nonlinear adaptive controller design for drug delivery in cancerous tumor chemotherapy

  2019cites this paper
• A curative combination cancer therapy achieves high fractional cell killing through low cross-resistance and drug additivity

  2019cites this paper
• Modeling and Optimization of Radio-Chemotherapy

  2019cites this paper
• The rationale of dose-response curves in selecting cancer drug dosing.

  2019cites this paper
• Hybrid Imaging and Radionuclide Therapy in Hemato-oncology

  2019cites this paper
• Effect of chemotherapy on cancer stem cells and tumor-associated macrophages in a prospective study of preoperative chemotherapy in soft tissue sarcoma

  2019influential citation
• Dynamics of tumor growth: chemotherapy and integrative oncology

  2019cites this paper
• A view on drug resistance in cancer

  2019cites this paper
• Cancer and AIDS

  2019cites this paper
• Basic principles of brain tumor chemotherapy

  2019cites this paper
• Nonlinear composite adaptive control of cancer chemotherapy with online identification of uncertain parameters

  2019cites this paper
• Principles of Dose, Schedule, and Combination Therapy

  2019cites this paper
• A curative combination therapy for lymphomas achieves high fractional cell killing through low cross-resistance and drug additivity but not synergy

  2019cites this paper
• Neoadjuvante Konzepte in der multimodalen Therapie von gastrointestinalen

  2019cites this paper
• Role of Muscarinic Acetylcholine Receptors in Breast Cancer: Design of Metronomic Chemotherapy

  2019cites this paper
• Optimizing chemo-scheduling based on tumor growth rates

  2018cites this paper
• Challenges and Opportunities in Dose Finding in Oncology and Immuno‐oncology

  2018cites this paper
• Super Twisting Sliding Mode Control of Cancer Chemotherapy

  2018cites this paper
• A mathematical model for chemoimmunotherapy of chronic lymphocytic leukemia

  2018cites this paper
• Effects of Pharmacokinetics and DNA Repair on the Structure of Optimal Controls in a Simple Model of Radio-Chemotherapy

  2018cites this paper
• Mechanisms of Anticancer Drugs

  2018cites this paper
• Cancer Biology and Survival Analysis in Cancer Trials: Restricted Mean Survival Time Analysis versus Hazard Ratios.

  2018cites this paper
• Strategies to improve outcomes of autologous hematopoietic cell transplant in lymphoma

  2018cites this paper
• Estimating intratumoral heterogeneity from spatiotemporal data

  2018cites this paper
• 17 – Basic Principles of Chemotherapy

  2018cites this paper
• Drug delivery of oral anti-cancer fluoropyrimidine agents

  2017cites this paper
• Dose- and time-dependence of the host-mediated response to paclitaxel therapy: a mathematical modeling approach

  2017cites this paper
• Phase III Randomized Trial of Dose Intensive Neoadjuvant Chemotherapy with or Without G-CSF in Locally Advanced Breast Cancer: Long-Term Results

  2017cites this paper
• In-vitro antiproliferative activity of M. Azedarach

  2017cites this paper
• Dose intense, dose dense and tailored dose adjuvant chemotherapy for early breast cancer: an evolution of concepts

  2017cites this paper
• Diagnostic applications of nuclear medicine: Lymphomas

  2017cites this paper
• Optimization of Radiation Dosing Schedules

  2017cites this paper
• Tumour and normal tissue radiobiology in mouse models: how close are mice to mini-humans?

  2017cites this paper